Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,110.00
-280.00 (-2.98%)
Apr 29, 2026, 2:20 PM KST
-31.86%
Market Cap 199.35B
Revenue (ttm) 210.25B
Net Income (ttm) -34.66B
Shares Out 21.23M
EPS (ttm) -1,633.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 381,664
Average Volume 234,705
Open 9,380.00
Previous Close 9,390.00
Day's Range 8,990.00 - 9,390.00
52-Week Range 8,560.00 - 13,480.00
Beta 0.53
RSI 42.69
Earnings Date May 14, 2026

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Sam... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

In 2025, KRX:000520's revenue was 210.25 billion, a decrease of -4.30% compared to the previous year's 219.70 billion. Losses were -34.66 billion, 515.8% more than in 2024.

Financial Statements

News

There is no news available yet.